<p>A. Spatial distribution of DZNep and gemcitabine within NPs. Co-encapsulating double-emulsion formulations were created using PLGA-<i>b</i>-PEG-OH (<i>left</i>), DSPE-PEG-OH (<i>middle</i>), and PLGA-<i>b</i>-PEG-TPP (<i>right</i>). B and E. TEM illustrates the inner core and outer shell of all the double-emulsion NPs created. Insets show the NPs at higher magnification. <i>Bars</i>, SD. <i>n</i> = 3. C. Release kinetics indicates the similarity between DZNep and gemcitabine release using the PLGA-<i>b</i>-PEG-OH formulation. D. Gemcitabine (<i>top</i>) and DZNep (<i>bottom</i>) in individual PLGA-<i>b</i>-PEG-OH formulations distinctly increased cytotoxicity in MIA PaCa-2. Significance between nanoparticles and free formulation is shown...
PD-1 inhibitor Keytruda combined with chemotherapy for Triple-negative breast cancer (TNBC) has been...
Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginy...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...
<p>A. Short exposure with DZNep for 4–8 h produced maximal cytotoxic effects. Cells were exposed wit...
ABSTRACT: Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-smal...
Dual enzymatic reactions were introduced to fabricate programmed gemcitabine (GEM) nanovectors for t...
Well-defined, heterotelechelic polymer prodrugs for combination therapy were synthesized by using a ...
Combination therapies against multiple targets are currently being developed to prevent resistance t...
<div><p>We evaluated the potential of an investigational histone methylation reversal agent, 3-deaza...
We evaluated the potential of an investigational histone methylation reversal agent, 3-deazaneplanoc...
<p>A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...
Gemcitabine (GEM) is a nucleoside analogue of deoxycytidine with limited therapeutic efficacy due to...
To enhance the stability of the anticancer drug gemcitabine (2′-deoxy-2′,2′-difluorocytidine), it wa...
In this study, Gemcitabine (GEM) HCl is loaded in long-circulating polymeric nanoparticles (NPs) usi...
Peptide nanomaterials have received a great deal of interest in drug-delivery applications due to th...
PD-1 inhibitor Keytruda combined with chemotherapy for Triple-negative breast cancer (TNBC) has been...
Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginy...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...
<p>A. Short exposure with DZNep for 4–8 h produced maximal cytotoxic effects. Cells were exposed wit...
ABSTRACT: Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-smal...
Dual enzymatic reactions were introduced to fabricate programmed gemcitabine (GEM) nanovectors for t...
Well-defined, heterotelechelic polymer prodrugs for combination therapy were synthesized by using a ...
Combination therapies against multiple targets are currently being developed to prevent resistance t...
<div><p>We evaluated the potential of an investigational histone methylation reversal agent, 3-deaza...
We evaluated the potential of an investigational histone methylation reversal agent, 3-deazaneplanoc...
<p>A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...
Gemcitabine (GEM) is a nucleoside analogue of deoxycytidine with limited therapeutic efficacy due to...
To enhance the stability of the anticancer drug gemcitabine (2′-deoxy-2′,2′-difluorocytidine), it wa...
In this study, Gemcitabine (GEM) HCl is loaded in long-circulating polymeric nanoparticles (NPs) usi...
Peptide nanomaterials have received a great deal of interest in drug-delivery applications due to th...
PD-1 inhibitor Keytruda combined with chemotherapy for Triple-negative breast cancer (TNBC) has been...
Combination chemotherapy is a common clinical practice in cancer treatment. Here, cyclic RGD (arginy...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...